Carmel B. Nanthakumar

An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis

Gísli Jenkins, Bethany B. Moore, Rachel C. Chambers et al. · American Journal of Respiratory Cell and Molecular Biology · 2017 · 404 citations · Full text

Potential Therapies, Antifibrotic Therapy, Inflammatory Lung Disease +20

The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis

Hannah V. Woodcock, Jessica Eley, Delphine Guillotin et al. · Nature Communications · 2018 · 219 citations · Full text

Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF

Paul F. Mercer, Hannah V. Woodcock, Jessica Eley et al. · Thorax · 2016 · 198 citations · Full text

Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort

Louise Organ, Anne-Marie R. Duggan, Eunice Oballa et al. · Respiratory Research · 2019 · 132 citations · Full text

Inflammation, Fibrosis, Antifibrotic Therapy +14

Severity of Lung Injury in Cyclooxygenase-2-Deficient Mice Is Dependent on Reduced Prostaglandin E2 Production

Rebecca J. Hodges, Gísli Jenkins, Caroline Wheeler‐Jones et al. · American Journal Of Pathology · 2004 · 124 citations · Full text

Acute Lung Injury, Inflammation, Asthma +13